2013 Fiscal Year Final Research Report
Novel therapy on sarcopenia by targeting Akt signaling
Project/Area Number |
24890178
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
General internal medicine (including Psychosomatic medicine)
|
Research Institution | Kagoshima University |
Principal Investigator |
AKASAKI Yuichi 鹿児島大学, 医歯(薬)学総合研究科, 助教 (00631920)
|
Project Period (FY) |
2012-08-31 – 2014-03-31
|
Keywords | 骨格筋 / 老化 / シグナル伝達 / 糖尿病 / 脂質 |
Research Abstract |
Akt1-mediated increase in muscle mass led to reductions in fat mass and hepatic steatosis in older animals, and corrected age-associated impairments in glucose metabolism. These results indicate that the loss of lean muscle mass is a significant contributor to the development of age-related metabolic dysfunction and that interventions that preserve or restore fast/glycolytic muscle may delay the onset of metabolic disease.
|
Research Products
(6 results)
-
-
[Journal Article] Novel therapy for atherosclerosis using recombinant immunotoxin against folate receptorβ-expressing macrophages2012
Author(s)
Furusho Y, Miyata M, Matsuyama T, Nagai T, Li H, Akasaki Y, Hamada N, Miyauchi T, Ikeda Y, Shirasawa T, Ide K, Tei C
-
Journal Title
J Am Heart Assoc
Volume: 1
Pages: e003079
DOI
Peer Reviewed
-
-
-
-